SE0004056D0 - N-type calcium channel antagonists for the treatment of pain - Google Patents
N-type calcium channel antagonists for the treatment of painInfo
- Publication number
- SE0004056D0 SE0004056D0 SE0004056A SE0004056A SE0004056D0 SE 0004056 D0 SE0004056 D0 SE 0004056D0 SE 0004056 A SE0004056 A SE 0004056A SE 0004056 A SE0004056 A SE 0004056A SE 0004056 D0 SE0004056 D0 SE 0004056D0
- Authority
- SE
- Sweden
- Prior art keywords
- pain
- treatment
- type calcium
- calcium channel
- channel antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0004056A SE0004056D0 (sv) | 2000-11-06 | 2000-11-06 | N-type calcium channel antagonists for the treatment of pain |
US10/415,783 US6841680B2 (en) | 2000-11-06 | 2001-10-31 | N-type calcium channel antagonists for the treatment of pain |
AU2002212897A AU2002212897A1 (en) | 2000-11-06 | 2001-10-31 | N-type calcium channel antagonists for the treatment of pain |
ES01981242T ES2319259T3 (es) | 2000-11-06 | 2001-10-31 | Antagonistas de canales calcicos de tipo n para el tratamiento del dolor. |
JP2002539329A JP2004513118A (ja) | 2000-11-06 | 2001-10-31 | 疼痛治療のためのn−型カルシウムチャンネル拮抗薬 |
EP01981242A EP1339690B1 (en) | 2000-11-06 | 2001-10-31 | N-type calcium channel antagonists for the treatment of pain |
PCT/SE2001/002391 WO2002036569A1 (en) | 2000-11-06 | 2001-10-31 | N-type calcium channel antagonists for the treatment of pain |
AT01981242T ATE421502T1 (de) | 2000-11-06 | 2001-10-31 | Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen |
DE60137534T DE60137534D1 (de) | 2000-11-06 | 2001-10-31 | Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0004056A SE0004056D0 (sv) | 2000-11-06 | 2000-11-06 | N-type calcium channel antagonists for the treatment of pain |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0004056D0 true SE0004056D0 (sv) | 2000-11-06 |
Family
ID=20281716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0004056A SE0004056D0 (sv) | 2000-11-06 | 2000-11-06 | N-type calcium channel antagonists for the treatment of pain |
Country Status (9)
Country | Link |
---|---|
US (1) | US6841680B2 (sv) |
EP (1) | EP1339690B1 (sv) |
JP (1) | JP2004513118A (sv) |
AT (1) | ATE421502T1 (sv) |
AU (1) | AU2002212897A1 (sv) |
DE (1) | DE60137534D1 (sv) |
ES (1) | ES2319259T3 (sv) |
SE (1) | SE0004056D0 (sv) |
WO (1) | WO2002036569A1 (sv) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2862301B1 (fr) * | 2003-11-17 | 2007-12-21 | Aventis Pharma Sa | Nouveau procede de preparation de quinoleines 3-fluorees |
EP1871372A4 (en) * | 2005-04-08 | 2010-06-02 | Neuromed Pharmaceuticals Ltd | COMBINATION THERAPY WHICH INCLUDES AN AGENT BLOCKING CALCIUM CHANNELS OF TYPE N FOR THE RELIEF OF PAIN |
EP2019676A2 (en) * | 2006-05-11 | 2009-02-04 | Neuromed Pharmaceuticals, Ltd. | Method for increasing the bioavailability of benzhydryl piperazine containing compounds |
PT2634177T (pt) * | 2010-10-29 | 2016-08-18 | Clino Ltd | Sonda de imagem de tau |
US8409560B2 (en) | 2011-03-08 | 2013-04-02 | Zalicus Pharmaceuticals Ltd. | Solid dispersion formulations and methods of use thereof |
JP2014507424A (ja) | 2011-03-08 | 2014-03-27 | ザリカス ファーマスーティカルズ リミテッド | 固体分散物製剤およびその使用方法 |
DE102016125645A1 (de) * | 2016-12-23 | 2018-06-28 | Forschungszentrum Jülich GmbH | D-enantiomere Peptide zur Therapie von chronischem und neuropathischem Schmerz |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2114727C (en) * | 1991-08-02 | 1996-12-10 | Mikel P. Moyer | Quinoline derivatives as immunostimulants |
-
2000
- 2000-11-06 SE SE0004056A patent/SE0004056D0/sv unknown
-
2001
- 2001-10-31 AT AT01981242T patent/ATE421502T1/de not_active IP Right Cessation
- 2001-10-31 JP JP2002539329A patent/JP2004513118A/ja active Pending
- 2001-10-31 WO PCT/SE2001/002391 patent/WO2002036569A1/en active Application Filing
- 2001-10-31 ES ES01981242T patent/ES2319259T3/es not_active Expired - Lifetime
- 2001-10-31 US US10/415,783 patent/US6841680B2/en not_active Expired - Fee Related
- 2001-10-31 DE DE60137534T patent/DE60137534D1/de not_active Expired - Fee Related
- 2001-10-31 AU AU2002212897A patent/AU2002212897A1/en not_active Abandoned
- 2001-10-31 EP EP01981242A patent/EP1339690B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1339690A1 (en) | 2003-09-03 |
US6841680B2 (en) | 2005-01-11 |
ES2319259T3 (es) | 2009-05-06 |
DE60137534D1 (de) | 2009-03-12 |
ATE421502T1 (de) | 2009-02-15 |
AU2002212897A1 (en) | 2002-05-15 |
EP1339690B1 (en) | 2009-01-21 |
US20040053965A1 (en) | 2004-03-18 |
JP2004513118A (ja) | 2004-04-30 |
WO2002036569A1 (en) | 2002-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0004053D0 (sv) | N-type calcium channel antagonists for the treatment of pain | |
ATE302770T1 (de) | Benzimidazolverbindungen die nociceptinrezeptoraffinität haben | |
ATE376996T1 (de) | Antibakterielle mittel | |
CY1107054T1 (el) | Ενωσεις διτοσυλικου αλατος κιναζολινης | |
ATE284392T1 (de) | Substituierte 2-phenylbenzimidazole, deren herstellung und anwendung | |
EP1233956A4 (en) | BRYOSTATIN ANALOGUES, METHODS OF SYNTHESIS AND USES | |
BE2011C037I2 (sv) | ||
DE60334379D1 (de) | Copolymerverbindung, diese enthaltende polymerzusammensetzung, bilderzeugungsverfahren und dieselbe benutzende bilderzeugungsvorrichtung | |
DE60107941D1 (de) | Blockcopolymerkautschuk, harzmodifizierer und harzzusammensetzung | |
EP0657942A3 (en) | Lateral bipolar transistor. | |
TR200102178T2 (tr) | CRF reseptör antagonistleri ve bunlarla ilgili yöntemler. | |
SE0102858D0 (sv) | N-type calcium channel antagonists for the treatment of pain | |
SE0004054D0 (sv) | N-type calcium channel antagonists for the treatment of pain | |
SE0004056D0 (sv) | N-type calcium channel antagonists for the treatment of pain | |
DE69727711D1 (de) | N-alkyl-ammonium-acetonitril-salze, methoden dazu und zusammensetzungen die diese enthalten | |
DE60139195D1 (de) | Aktivierbare polymerzusammensetzung, und gegenstände, die diese nutzen | |
NO20030868D0 (no) | N-(3,5-diklor-2-metoksyfenyl)-4-metoksy-3-piperazin-1-yl- benzensulfonamid | |
DE69735479D1 (de) | Metalloproteinase inhibitoren | |
NO20054668L (no) | Aplidin for multippelt myelom-behandling | |
NO20006699D0 (no) | Forbindelser med veksthormonfrigjörende egenskaper | |
SE0004055D0 (sv) | N-type calcium channel antagonists for the treatment of pain | |
DE60129123D1 (de) | BIOLOGISCH AKTIVE 4H-BENZOi1,4öOXAZIN-3-ONE | |
AU2002210491A1 (en) | Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof | |
PT1212119E (pt) | Utilizacao de ciamemazina no tratamento do desmame subito de benzodiazepinas | |
ATE323493T1 (de) | Gesteuerte freisetzung von antidepressiva |